Navigation Links
Biologists develop efficient genetic modification of human embryonic stem cells
Date:1/7/2010

uccessfully transferred a defective copy of the gene p53, which suppresses cancer, into a human embryonic stem cell line. By repeating the process in a second round, they developed a line of cells in which both copies of the genes were disrupted.

They also report success with a different gene, ATM, which when mutated in humans causes Ataxia-telangiectasia, a disease characterized by a host of systemic defects including increased cancer risk, degeneration of specific types of brain cells and degraded telomeres, the protective caps at the end of each chromosome.

Genetically engineered mice with two bad copies of the ATM gene share some of these traits with human patients, but not all. Neurons don't degenerate in ATM mice, for example, and the telomeres are long. "If you want to study accelerated shortening of telomeres, you can't do it in the mouse. You can only do it in human cells," Xu said.

Those differences propelled Xu's group to develop human cell lines instead, with the hope that some of the processes that go wrong in human patients could be studied in the lab. Already, they have demonstrated that their ATM-deficient embryonic stem cell line has damaged telomeres. Other characteristics, such as the degeneration of specific types of neurons, will be the subject of future experiments, Xu said.

The authors say their approach can easily be adapted to modify other human genes within other stem cells lines. For their initial work, Xu's group used a cell line that easily forms new colonies from single cells, but they also repeated the procedure in a cell line called H9, which has proved difficult to manipulate.

Because H9 was among the few cells lines approved for use by researchers funded by the federal government before new lines began to be approved in mid-December 2009, many researchers already have considerable experience with coaxing the cells into differentiating into specific types of tissues, for example, which w
'/>"/>

Contact: Yang Xu
scinews@ucsd.edu
University of California - San Diego
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Biologists Question Animal Brain Size Theory
2. Where tumor cells boldly go: Weill Cornell cancer biologists shed light on the metastatic niche
3. Cell biologists identify new tumor suppressor for lung cancer
4. Microbiologists receive top Canadian recognition
5. Boston College biologists build a better mouse model for cancer research
6. Biologists Discover How Dengue Virus Matures
7. FDA clears TransOral robotic surgery developed at Penn
8. Michael J. Fox Foundation Awards $1 Million for Critical Step Toward Development of Dyskinesia Treatments
9. Nu-Tek Products Develops Cultured Soymilk Powder
10. Milton & DeKruif Launches New Client Development Campaign
11. Safety and Quality Software Developer Quantros, Inc. Launches Healthcare IT Consulting Division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... York (PRWEB) July 25, 2014 As ... forward in U.S. courts, Bernstein Liebhard LLP notes that ... petition by the consumer advocacy group, Public Citizen, to ... In a letter dated May 1, 2014, and released ... the group’s petition for a ban on the marketing ...
(Date:7/25/2014)... A new system that sent patients to designated cardiac ... of sudden cardiac arrest in Arizona, according to a ... Emergency Medicine . , "We knew lives would ... edge guidelines for post-cardiac arrest care and we were ... similar to what is done for Level 1 trauma ...
(Date:7/25/2014)... 25, 2014 CarePoint Health is proud ... Boylan, has joined our network, CarePoint Health Medical Group. ... of highly skilled and experienced physicians comprise CarePoint Health ... practices in Hudson County, representing a wide range of ... provide the highest quality care to patients and families ...
(Date:7/25/2014)... The European liquid chromatography reagents report defines and segments ... of revenue. The liquid chromatography reagents market in Europe ... is estimated to grow to around $1581.8 million by ... to 2018. , Browse through the TOC of the ... of the in-depth analysis provided. This also provides a ...
(Date:7/25/2014)... NH, 7/25/14) Researchers at Dartmouth-Hitchcock Norris Cotton Cancer ... system so it recognizes and attacks invading cancer cells. ... accepting everything as normal, even while cancer cells ... discussed in a review article published this week in ... jumpstart the body,s ability to fight tumors. Nanoparticles ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 4Health News:New EMS system in Arizona dramatically improves survival from cardiac arrest 2Health News:New EMS system in Arizona dramatically improves survival from cardiac arrest 3Health News:Dr. Boylan Joins CarePoint Health Medical Group 2Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 2Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 3Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Scientists test nanoparticle 'alarm clock' to awaken immune systems put to sleep by cancer 2
... , Irvine, Calif., Sept. 26, 2011 Notable levels of ... heart attacks and strokes in people with diabetes and metabolic ... Disease Prevention Program. The researchers also found that individuals ... calcium had cardiac-event risks as low as many without these ...
... R.I. A new study from Rhode Island Hospital researchers ... in patients who are taking non-steroidal anti-inflammatory drugs (NSAIDs) such ... the safety of NSAID medications in clinically relevant animal models ... in the current issue of the journal Surgery . ...
... at Women & Infants Hospital of Rhode Island, Holly ... College of Nurse-Midwives (ACNM), returns to her Rhode Island ... commendation to the Women,s Care Nurse-Midwives. This national ... compassionate midwifery care to families through expanded access, unique ...
... HealthDay Reporter , FRIDAY, Sept. 23 (HealthDay News) -- ... not necessarily living better. And that,s especially true for people who ... expect to live almost six more years of his life with ... the extra time with diabetes is now 2.5 years. "At ...
... 2011) - AMRI (NASDAQ: AMRI) today announced the ... Administration (FDA) regarding its Burlington, Massachusetts aseptic finish-and-fill facility, ... written responses to a August 2010 warning letter and ... actions proposed by AMRI, once fully implemented, should adequately ...
... particular agents during pregnancy could give birth to children with ... The study will be presented today (26 September 2011) ... It is well known that when people are ... However, there has been little research investigating whether a mother,s ...
Cached Medicine News:Health News:Rhode Island Hospital researchers find possible cardiovascular risk with NSAID use 2Health News:Americans Spending More of Their Lives Struggling With Diabetes 2Health News:Americans Spending More of Their Lives Struggling With Diabetes 3Health News:A mother's occupation while pregnant can cause asthma in children 2
(Date:7/24/2014)... , July 24, 2014  PTC Therapeutics, Inc. ... Company will host a webcast conference call to report ... update on the company,s business and outlook on Thursday, ... opening of the market. The call ... (973) 935-8152 (international) five minutes prior to the start ...
(Date:7/24/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... today reported financial results for the first fiscal quarter ... , Revenues of $47.5 million, up 10% over ... $0.21, up 50% over last year,s comparable quarter. ... $7.2 million, up 20% over last year,s comparable quarter. ...
(Date:7/24/2014)... IGI Laboratories, Inc. (NYSE MKT: IG), a ... pharmaceutical company, today announced it has accepted  Damian ... Finio has accepted a senior level finance position at ... acceptance of his new position, Mr. Finio will be ... IGI Laboratories, Inc.  The effective date of his resignation ...
Breaking Medicine Technology:Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11IGI Laboratories, Inc. Announces Change To Its Board Of Directors 2
... Nov. 2, 2011 LORENZ customers and business partners have ... Article 57(2) of Regulation (EC) 726/2004 and its impact on ... Interest Group for EVMPD – XEVPRM. One of ... registration are the Requirements of Article 57(2) of Regulation (EC) ...
... GenVec, Inc. (Nasdaq: GNVC ) will report financial ... 9, 2011, before the U.S. financial markets open. The announcement ... 10:00 a.m. EST to discuss the company,s third quarter financial ... the live conference call, please dial 877-558-0567 (U.S. or Canada) ...
Cached Medicine Technology:LORENZ' Response to New EU PV Legislation - Regulation No. 1235/2010 and EVMPD 2GenVec to Release Third Quarter 2011 Financial Results and Conduct a Conference Call on November 9, 2011 2
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: